Serum Levels of Soluble CD40 Ligand at Flare and at Remission in Patients with Systemic Lupus Erythematosus

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Rheumatology

• Publication date

  2009-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3899/jrheum.080978PMID 19332622
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value

  2007cited by this paper
• Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.

  2006cited by this paper
• Overview of the Actions of Glucocorticoids on the Immune Response: A Good Model to Characterize New Pathways of Immunosuppression for New Treatment Strategies

  2004cited by this paper
• Soluble CD40 ligand in acute coronary syndromes.

  2003cited by this paper
• Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial.

  2002cited by this paper
• The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review

  2001cited by this paper
• The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.

  2001cited by this paper
• Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching.

  2001cited by this paper
• Mechanisms and clinical relevance of nongenomic glucocorticoid actions

  2000cited by this paper
• Reply to Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand

  2000cited by this paper
• The soluble CD40 ligand sCD154 in systemic lupus erythematosus.

  1999influential reference
• Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera.

  1999cited by this paper
• Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.

  1998cited by this paper
• Exogenous CD40 ligand induces a pulmonary inflammation response.

  1997cited by this paper
• Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

  1997cited by this paper
• Informed consent in human experimentation before the Nuremberg code

  1996cited by this paper
• Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.

  1996cited by this paper
• Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.

  1996cited by this paper
• Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.

  1996cited by this paper
• A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation

  1995cited by this paper
• Regulation of human B cell function by recombinant CD40 ligand and other TNF-related ligands.

  1995cited by this paper
• Recombinant Soluble Trimeric CD40 Ligand Is Biologically Active *

  1995cited by this paper
• Molecular mechanisms for B lymphocyte selection: induction and regulation of antigen-receptor-mediated apoptosis of mature B cells in normal mice and their defect in autoimmunity-prone mice.

  1994cited by this paper
• Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

  1992cited by this paper
• Evidence that glucocorticosteroids block expression of the human interleukin-6 gene by accessory cells.

  1990cited by this paper
• Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells.

  1987cited by this paper
• Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA.

  1984cited by this paper
• Hydrocortisone-mediated inhibition of monocyte antigen presentation: dissociation of inhibitory effect and expression of DR antigens.

  1984cited by this paper
• Prednisone-induced alterations of circulating human lymphocyte subsets.

  1983cited by this paper

• Evaluation of Plasma Soluble Cd40 Ligand Levels in Children with Familial Mediterranean Fever and Its Relationship with Carotid Intima–Media Thickness

  2025cites this paper
• Genetic polymorphisms near IL-21 gene associated with Th17 cytokines confer risk for systemic lupus erythematosus in Chinese Han population

  2019cites this paper
• Lupus nephritis and B-cell targeting therapy

  2017cites this paper
• Elevated levels of soluble CD40 ligand are associated with antiphospholipid antibodies in patients with systemic lupus erythematosus.

  2017cites this paper
• Association study of CD154 polymorphisms and serum CD154 level with systemic lupus erythematous in Chinese population

  2017cites this paper
• The Serum Levels of the Soluble Factors sCD40L and CXCL1 Are Not Indicative of Endometriosis

  2016cites this paper
• Expression and significance of leukocyte membrane cofactor protein transcript in systemic lupus erythematosus

  2012cites this paper
• Associations between the Expression of Epigenetically Regulated Genes and the Expression of DNMTs and MBDs in Systemic Lupus Erythematosus

  2012cites this paper
• Relationship of leukocyte CR1 transcript and protein with the pathophysiology and prognosis of systemic lupus erythematosus: A follow-up study

  2011cites this paper
• Serum Protein Profiling of Systemic Lupus Erythematosus and Systemic Sclerosis Using Recombinant Antibody Microarrays*

  2011cites this paper
• Involvement of CD40–CD40 Ligand in Uncomplicated and Refractory Celiac Disease

  2011cites this paper
• Tuning of CD40–CD154 Interactions in Human B-Lymphocyte Activation: A Broad Array of In Vitro Models for a Complex In Vivo Situation

  2011cites this paper
• Platelets, inflammation and tissue regeneration

  2011cites this paper
• Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity.

  2010cites this paper